A cell ELISA based method for exosome detection in diagnostic and therapeutic applications

  • Shabanali Khodashenas
  • Saeed Khalili
  • Mehdi Forouzandeh MoghadamEmail author
Original Research Paper



Exosomes are nano-scaled carriers of miRNA, mRNA and proteins which are secreted from viable cells. Exosome detection within serum, saliva and semen offers diagnostic value for detection of various diseases including cancer. In the present study, we have lunched an in vitro study to develop a more efficient method for exosome detection. In this regard, the recombinant LAMP-DARPins (capable of Her2 targeting) gene was packed within the lentiviral particles and stably transferred into the HEK293T cells. The morphology and sizes of the obtained exosomes were characterized by TEM and zeta sizer. The expression of LAMP-DARPins antigen on the exosome surface was verified by western blotting. Ultimately, the efficiency of cell surface ELISA in suspension method was examined for exosome detection.


The exosome particles were successfully harvested and purified from transfected cells. The sizes of exosome particles were determined to be 90 nm using zeta sizer instrument. The TEM scan showed that the exosomes are cap like shaped and their sizes range between 40 and 150 nm. An observed 120 kDa band on western blotting paper indicated the LAMP-DARPins antigen expression on exosome surfaces. The results of cell surface ELISA in suspension method were superior to the results of conventional cell ELISA.


It could be concluded that the cell surface ELISA in suspension method could be an amenable method to detect exosome particles within the biological samples. Moreover, the method could be modified to evaluate the ability of exosomes to interact with target cells in both diagnostic and therapeutic applications.


Cell surface ELISA in suspension DARPins Exosome LAMP2 



The authors wish to thank Tarbiat Modares University and Iranian National Science Foundation for supporting the conduct of this research.

Compliance with ethical standards

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.


  1. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29:341CrossRefGoogle Scholar
  2. Boersma YL, Plückthun A (2011) DARPins and other repeat protein scaffolds: advances in engineering and applications. Curr Opin Biotechnol 22:849–857CrossRefGoogle Scholar
  3. Ciravolo V et al (2012) Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy. J Cell Physiol 227:658–667CrossRefGoogle Scholar
  4. Hashemi ZS, Khalili S, Forouzandeh Moghadam M, Sadroddiny E (2017) Lung cancer and miRNAs: a possible remedy for anti-metastatic, therapeutic and diagnostic applications. Expert Rev Respir Med 11:147–157CrossRefGoogle Scholar
  5. Koyama Y, Ito T, Hasegawa A, Eriguchi M, Inaba T, Ushigusa T, Sugiura K (2016) Exosomes derived from tumor cells genetically modified to express Mycobacterium tuberculosis antigen: a novel vaccine for cancer therapy. Biotechnol Lett 38:1857–1866CrossRefGoogle Scholar
  6. Limoni SK, Moghadam MF, Moazzeni SM, Gomari H, Salimi F (2018) Engineered exosomes for targeted transfer of siRNA to HER2 positive breast cancer cells. Appl Biochem Biotechnol 187:1–13Google Scholar
  7. Ludwig A-K, Giebel B (2012) Exosomes: small vesicles participating in intercellular communication. Int J Biochem Cell Biol 44:11–15CrossRefGoogle Scholar
  8. Mathivanan S, Ji H, Simpson RJ (2010) Exosomes: extracellular organelles important in intercellular communication. J Proteom 73:1907–1920CrossRefGoogle Scholar
  9. Michael A, Bajracharya SD, Yuen PS, Zhou H, Star RA, Illei GG, Alevizos I (2010) Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis 16:34–38CrossRefGoogle Scholar
  10. Münch RC et al (2011) DARPins: an efficient targeting domain for lentiviral vectors. Mol Ther 19:686–693CrossRefGoogle Scholar
  11. Raimondo F, Morosi L, Chinello C, Magni F, Pitto M (2011) Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery. Proteomics 11:709–720CrossRefGoogle Scholar
  12. Rountree RB et al (2011) Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy. Can Res 4076:2010Google Scholar
  13. Schorey JS, Bhatnagar S (2008) Exosome function: from tumor immunology to pathogen biology. Traffic 9:871–881CrossRefGoogle Scholar
  14. Théry C, Amigorena S, Raposo G, Clayton A (2006) Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 30:21–23CrossRefGoogle Scholar
  15. Tian Y et al (2014) A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 35:2383–2390CrossRefGoogle Scholar
  16. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654CrossRefGoogle Scholar
  17. Vlassov AV, Magdaleno S, Setterquist R, Conrad R (2012) Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochem Biophys Acta 1820:940–948CrossRefGoogle Scholar
  18. Wolfers J et al (2001) Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 7:297CrossRefGoogle Scholar
  19. Yoshioka Y et al (2014) Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen. Nat Commun 5:3591CrossRefGoogle Scholar
  20. Zahnd C et al (2007) A designed ankyrin repeat protein evolved to picomolar affinity to Her2. J Mol Biol 369:1015–1028CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  • Shabanali Khodashenas
    • 1
    • 2
    • 4
  • Saeed Khalili
    • 3
    • 4
  • Mehdi Forouzandeh Moghadam
    • 4
    Email author
  1. 1.Molecular and Cell Biology Research Center, Faculty of MedicineMazandaran University of Medical SciencesSariIran
  2. 2.Immunogenetics Research CenterMazandaran University of Medical SciencesSariIran
  3. 3.Department of Biology SciencesShahid Rajaee Teacher Training UniversityTehranIran
  4. 4.Department of Medical Biotechnology, Faculty of Medical SciencesTarbiat Modares UniversityTehranIran

Personalised recommendations